Welcome to our dedicated page for InnovAge Holding SEC filings (Ticker: INNV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
InnovAge Holding Corp. filings document the reporting framework for a Nasdaq-listed healthcare services company built around the Program of All-inclusive Care for the Elderly (PACE). Form 8-K reports furnish quarterly operating results, financial-condition updates, Regulation FD investor presentations, guidance-related materials, and governance events such as director appointments and executive transitions.
Proxy materials describe annual meeting matters, classified-board elections, committee governance, executive and director compensation, stockholder voting procedures, and auditor ratification. The filings also identify InnovAge common stock on the Nasdaq Global Select Market and include emerging-growth-company status, common-stock registration details, capital-structure information, and public-company reporting obligations tied to its PACE care model.
InnovAge Holding Corp. (INNV) has filed a preliminary prospectus supplement for a secondary offering of 10,000,000 existing shares of common stock to be sold by selling security holder TCO Group Holdings, L.P. The underwriters have a 30‑day option to purchase up to 1,500,000 additional shares from the same holder. InnovAge will not receive any proceeds from these sales; all net proceeds go to the selling security holder.
The company’s common stock trades on Nasdaq under the symbol INNV, with a last reported price of $10.60 per share on September 21, 2026. Shares outstanding were 136,451,425 as of that date. As of June 30, 2026, InnovAge served approximately 8,230 PACE participants across 20 PACE centers in six states under its fully capitated, value‑based care model for frail, largely dual‑eligible seniors. After this offering, Principal Shareholders are expected to retain about 75.2% of voting power (74.1% if the option is fully exercised), maintaining their ability to control shareholder votes and board composition.
InnovAge Holding Corp. (INNV) reported strong top-line growth in its PACE-based senior care platform for the year ended June 30, 2026. Total revenues rose to $989.7 million from $853.7 million, driven mainly by capitation revenue of $988.4 million, while serving about 8,230 participants across 20 PACE centers in six states.
Operating performance improved markedly, shifting from a $29.8 million operating loss in 2025 to $2.6 million operating income in 2026, and net loss attributable to InnovAge narrowed to $2.5 million. Adjusted EBITDA increased to $94.6 million from $34.5 million, though this excludes significant litigation and one-time items. Cash and cash equivalents grew to $97.9 million, operating cash flow doubled to $64.7 million, and term debt declined to $48.8 million, with an additional $93.8 million of revolver capacity available. Auditors issued unqualified opinions on both the financial statements and internal control over financial reporting, highlighting estimated claims liability as a critical audit matter.
InnovAge Holding Corp. (INNV) reported that major shareholder TCO Group Holdings, L.P. recorded an "other" disposition of 411,515 shares of common stock on September 3, 2026, as a distribution to a limited partner as consideration for that partner’s interest in TCO Group Holdings.
After this distribution, TCO Group Holdings, L.P. reports holding 112,576,555 shares of InnovAge common stock directly, with voting and dispositive power exercised by an LP Board composed of designees of WCAS and Apax.
InnovAge Holding Corp. (INNV) had a Form 4 filed by a group of ten-percent owners associated with the Apax X funds reporting an internal restructuring transaction. On September 3, 2026, 411,515 shares of common stock were disposed of through a distribution by TCO Group Holdings, L.P. to one of its limited partners at a stated price of $0.00 per share, rather than through an open-market sale. Following this distribution, entities in the group continued to report 112,576,555 shares of InnovAge common stock held indirectly through TCO Group Holdings, L.P., with each entity disclaiming beneficial ownership except to the extent of its pecuniary interest.
InnovAge Holding Corp. (INNV) received notice that investment entities affiliated with Welsh, Carson, Anderson & Stowe reported an indirect disposition of 411,515 shares of common stock on September 3, 2026, reflecting a distribution by TCO Group Holdings, L.P. to one of its limited partners as consideration for that partner’s interest. Following this restructuring-related distribution, the affiliated holders continue to report indirect ownership of 112,576,555 shares of InnovAge common stock, with complex partnership and management entities disclaiming beneficial ownership except to the extent of their pecuniary interests. No transactions were reported under a Rule 10b5-1 trading plan.
InnovAge Holding Corp. (INNV) reported strong fiscal 2026 improvement, with total revenue of $989.7 million, up 15.9% from $853.7 million in 2025, driven almost entirely by capitation revenue from its PACE model. Net loss narrowed sharply to $0.7 million from $35.3 million, and income before income taxes was $0.3 million versus a prior-year loss of $34.0 million.
Profitability metrics strengthened meaningfully on an operating basis: Adjusted EBITDA rose to $94.6 million from $34.5 million, lifting Adjusted EBITDA margin to 9.6% from 4.0%, while Center-level Contribution Margin increased to $227.8 million, or 23.0% of revenue, from $153.6 million, or 18.0%. Operating cash flow more than doubled to $64.7 million, and cash and cash equivalents increased to $97.9 million at June 30, 2026.
InnovAge ended the year serving approximately 8,230 participants across 20 centers and issued fiscal 2027 guidance for revenue of $1.05–$1.085 billion and Adjusted EBITDA of $105–$115 million, with expected member months of 101,000–102,500 and census of 8,625–8,850.
InnovAge Holding Corp. executive Paul Taheri, Chief Medical Officer, reported initial beneficial ownership on a Form 3. He holds 38,765 shares/units as Restricted Stock Units that will be settled in common stock upon vesting. This includes 17,361 RSUs vesting ratably over three years beginning January 27, 2027 and 21,404 RSUs vesting ratably over three years beginning July 22, 2027, in each case subject to his continued service with the company.
InnovAge Holding Corp. has filed a shelf registration to enable selling security holders to resell up to 112,988,070 shares of common stock from time to time. These are existing shares held primarily by TCO Group Holdings, L.P.; the company itself is not selling shares and will receive no proceeds from these resales.
As of April 30, 2026, InnovAge had 135,736,393 shares outstanding. Its stock trades on Nasdaq under the symbol INNV, with a July 30, 2026 last sale price of $11.60 per share. The filing may increase potential share overhang if large holders choose to sell.
InnovAge operates the Program of All-Inclusive Care for the Elderly (PACE), serving about 8,050 participants across 20 centers in six states, under capitated contracts with Medicare, Medicaid and other government payors. Key risks highlighted include dependence on a limited number of government payors, potential Medicaid cuts under the One Big Beautiful Bill Act, ongoing inspections and investigations, litigation and stockholder proceedings, concentration in Colorado, labor and inflation pressures, Nasdaq listing compliance, and its status as a controlled company with significant governance rights for its principal shareholders.
BLAIR PATRICK T reported acquisition or exercise transactions in this Form 4 filing.
Patrick T Blair, Chief Executive Officer of InnovAge Holding Corp., received a grant of 78,397 Restricted Stock Units (RSUs) of common stock on 2026-07-27. These RSUs will vest in three equal installments on each anniversary of the grant date, subject to his continued service. Following this award, he directly holds 751,047 shares of common stock.